Spots Global Cancer Trial Database for Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer
Official Title: Oncologic Outcomes of Single-incision Laparoscopic Surgery Versus Conventional Laparoscopic Surgery for Colorectal Cancer: A Multi-center, Prospective, Open Label, Non-inferiority, Randomized Controlled Trial
Study ID: NCT04527861
Study Description
Brief Summary: This study is designed to investigate long-term oncologic outcomes of single-incision laparoscopic surgery (SILS) compared to conventional laparoscopic surgery (CLS) for colorectal cancer.
Detailed Description: In order to improve cosmetic effect and reduce postoperative pain, single-incision laparoscopic surgery (SILS) is attracting increasing attention. SILS is considered to be the next major advance in the progress of minimally invasive surgical approaches to colorectal disease that is more feasible in generalized use. In most previous studies, SILS for colorectal cancer was feasible and short-term safe compared to conventional laparoscopic surgery (CLS) . However, there is still controversy over its potential better cosmetic effect and less postoperative pain. Moreover, the long-term oncologic outcomes are still inconclusive as only a few studies showed long-term survival data. Up to now, most studies were limited to their retrospective nature and small samples. So more studies, especially large-scale, randomized controlled trials are needed to establish the best indications for SILS for colorectal cancer.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The 940th Hospital of Joint Logistic Support Force of Chinese of PLA, Lanzhou, Gansu, China
Shengjing Hospital, Shenyang, Liaoning, China
Liaoning Tumor Hospital & Institute, Shenyang, Liaoning, China
Shandong Provincial Hospital, Jinan, Shandong, China
The General Hospital of Western Theater Command, Chendu, Sichuan, China
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
Shanghai Cancer Center, Shanghai, , China
Dongfang Hospital Affiliated to Tongji University, Shanghai, , China
RenJi Hospital, Shanghai, , China
Changhai Hospital, Shanghai, , China
Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, , China
Contact Details
Name: Ren Zhao, MD, PHD
Affiliation: Ruijin Hospitlal , Shanghai Jiaotong University School of Medicine
Role: PRINCIPAL_INVESTIGATOR
Name: Chun Song, MD
Affiliation: Dongfang Hospital Affiliated to Tongji University
Role: STUDY_DIRECTOR
Name: Ye Xu, MD
Affiliation: Shanghai Cancer Center
Role: STUDY_DIRECTOR
Name: Liqiang Hao, MD
Affiliation: Changhai Hospital
Role: STUDY_DIRECTOR
Name: Hong Zhang, MD
Affiliation: Shengjing Hospital
Role: STUDY_DIRECTOR
Name: Hong Zhou, MD
Affiliation: RenJi Hospital
Role: STUDY_DIRECTOR
Name: Qingtong Zhang, MD
Affiliation: Liaoning Tumor Hospital & Institute
Role: STUDY_DIRECTOR
Name: Shiliang Tu, MD
Affiliation: Zhejiang Provincial People's Hospital
Role: STUDY_DIRECTOR
Name: Xiaoqiao Zhang, MD
Affiliation: Shandong Provincial Hospital
Role: STUDY_DIRECTOR
Name: Lin Zhang, MD
Affiliation: The General Hospital of Western Theater Command
Role: STUDY_DIRECTOR
Name: Feng Gao, MD
Affiliation: The 940th Hospital of Joint Logistic Support Force of Chinese of PLA
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
